Findling, J. W., Fleseriu, M., Newell-Price, J., Petersenn, S., Pivonello, R., Kandra, A., . . . Biller, B. M. K. (2016). Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study. Endocrine.
Citação norma ChicagoFindling, James W., Maria Fleseriu, John Newell-Price, Stephan Petersenn, Rosario Pivonello, Albert Kandra, Alberto M. Pedroncelli, and Beverly M. K. Biller. "Late-night Salivary Cortisol May Be Valuable for Assessing Treatment Response in Patients With Cushing’s Disease: 12-month, Phase III Pasireotide Study." Endocrine 2016.
ציטוט MLAFindling, James W., et al. "Late-night Salivary Cortisol May Be Valuable for Assessing Treatment Response in Patients With Cushing’s Disease: 12-month, Phase III Pasireotide Study." Endocrine 2016.